Stonepine Capital Management »

Evaxion Biotech A/S shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Evaxion Biotech A/S (EVAX) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Evaxion Biotech A/S

Tip: Access up to 7 years of quarterly data

All positions including Evaxion Biotech A/S held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evaxion Biotech A/S by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $95k 20k 4.77

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Nektar Therapeutics Com New Call Option (NKTR)
Zevra Therapeutics Com New (ZVRA)
Inhibikase Therapeutics Com New (IKT)
Abeona Therapeutics Com New Call Option (ABEO)
Indivior Ord
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Kazia Therapeutics Sponsored Ads (KZIA)
Xoma Royalty Corporation Com New (XOMA)
Verrica Pharmaceuticals Com Shs (VRCA)
Cybin Com New (HELP)
Tela Bio (TELA)
ACADIA Pharmaceuticals (ACAD)

View all positions for Stonepine Capital Management

Top funds holding Evaxion Biotech A/S

Ikarian Capital
Point72 Asset Management
Rhumbline Advisers
Stonepine Capital Management
Boothbay Fund Management
Wesbanco Trust And Investments
Northwestern Mutual Wealth Management Company
GAMMA Investing
UBS Group
EverSource Wealth Advisors
SBI Securities
Bessemer

View all funds holding Evaxion Biotech A/S